ATE432078T1 - Kleine peptide und methoden zur behandlung von asthma und entzündungen - Google Patents

Kleine peptide und methoden zur behandlung von asthma und entzündungen

Info

Publication number
ATE432078T1
ATE432078T1 AT98935561T AT98935561T ATE432078T1 AT E432078 T1 ATE432078 T1 AT E432078T1 AT 98935561 T AT98935561 T AT 98935561T AT 98935561 T AT98935561 T AT 98935561T AT E432078 T1 ATE432078 T1 AT E432078T1
Authority
AT
Austria
Prior art keywords
phe
methods
tyr
inflammation
small peptides
Prior art date
Application number
AT98935561T
Other languages
English (en)
Inventor
John Houck
Original Assignee
Mowycal Lending Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mowycal Lending Llc filed Critical Mowycal Lending Llc
Application granted granted Critical
Publication of ATE432078T1 publication Critical patent/ATE432078T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98935561T 1997-11-13 1998-07-07 Kleine peptide und methoden zur behandlung von asthma und entzündungen ATE432078T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6533697P 1997-11-13 1997-11-13
PCT/US1998/014103 WO1999025372A1 (en) 1997-11-13 1998-07-07 Small peptides and methods for treatment of asthma and inflammation

Publications (1)

Publication Number Publication Date
ATE432078T1 true ATE432078T1 (de) 2009-06-15

Family

ID=22062006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935561T ATE432078T1 (de) 1997-11-13 1998-07-07 Kleine peptide und methoden zur behandlung von asthma und entzündungen

Country Status (12)

Country Link
US (17) US6391856B1 (de)
EP (1) EP1037651B1 (de)
JP (1) JP2002516820A (de)
KR (1) KR100629546B1 (de)
CN (1) CN1282253A (de)
AT (1) ATE432078T1 (de)
AU (1) AU8477998A (de)
BR (1) BR9815288A (de)
CA (1) CA2309639C (de)
DE (1) DE69840851D1 (de)
ES (1) ES2326500T3 (de)
WO (1) WO1999025372A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE432078T1 (de) 1997-11-13 2009-06-15 Mowycal Lending Llc Kleine peptide und methoden zur behandlung von asthma und entzündungen
CA2353550A1 (en) * 1998-12-03 2000-06-08 Histatek, Llc Small peptides and methods for treatment of asthma and inflammation
BR0009226A (pt) * 1999-03-22 2001-12-26 Histatek Llc Método para tratar fibrose em um mamìfero
CN1367700A (zh) * 1999-07-16 2002-09-04 海斯塔泰克有限责任公司 用于下调lgE的小肽和方法
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
CN100497374C (zh) * 1999-10-15 2009-06-10 莫维克借贷有限责任公司 与g蛋白激酶信号途径修饰剂形成的n-甲酰基肽受体复合物
US20060264393A1 (en) 2002-12-30 2006-11-23 Yoram Groner Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
EP1587482A4 (de) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation Entzündungshemmende zusammensetzungen und ihre verwendungen
CN101693031A (zh) 2003-11-18 2010-04-14 诺瓦提斯公司 Kit突变形式的抑制剂
EP2532353A1 (de) * 2004-03-19 2012-12-12 Herbs Spring, LLC Kräutertherapie zur Behandlung von Asthma
CA2606716C (en) 2005-05-02 2013-07-23 Novartis Ag Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis
US20070111965A1 (en) * 2005-11-15 2007-05-17 Kipp James E Compositions comprising lipoxygenase inhibitors and cyclodextrin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI91859C (fi) * 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
NZ314680A (en) 1989-05-09 2000-08-25 Ortho Pharma Corp Treating localised infection or inflammation with a therapeutically conjugated chemotactic peptide
GB8919504D0 (en) * 1989-08-29 1989-10-11 Leo Pharm Prod Ltd Chemical compounds
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
ATE432078T1 (de) 1997-11-13 2009-06-15 Mowycal Lending Llc Kleine peptide und methoden zur behandlung von asthma und entzündungen
CA2353550A1 (en) 1998-12-03 2000-06-08 Histatek, Llc Small peptides and methods for treatment of asthma and inflammation

Also Published As

Publication number Publication date
US8012934B2 (en) 2011-09-06
US6462020B1 (en) 2002-10-08
US20080214472A1 (en) 2008-09-04
US20120058958A1 (en) 2012-03-08
US8809281B2 (en) 2014-08-19
US20120094938A1 (en) 2012-04-19
US20130274208A1 (en) 2013-10-17
US8097589B2 (en) 2012-01-17
CA2309639A1 (en) 1999-05-27
ES2326500T3 (es) 2009-10-13
US20080214475A1 (en) 2008-09-04
WO1999025372A1 (en) 1999-05-27
JP2002516820A (ja) 2002-06-11
EP1037651A1 (de) 2000-09-27
AU8477998A (en) 1999-06-07
US20080214473A1 (en) 2008-09-04
US20130252907A1 (en) 2013-09-26
US20030013658A1 (en) 2003-01-16
US20080214478A1 (en) 2008-09-04
EP1037651B1 (de) 2009-05-27
US20080187994A1 (en) 2008-08-07
US6391856B1 (en) 2002-05-21
US20080214476A1 (en) 2008-09-04
BR9815288A (pt) 2001-02-13
CA2309639C (en) 2010-03-23
US20080214477A1 (en) 2008-09-04
KR20010032072A (ko) 2001-04-16
US20080214474A1 (en) 2008-09-04
DE69840851D1 (de) 2009-07-09
EP1037651A4 (de) 2001-12-19
US7994137B2 (en) 2011-08-09
CN1282253A (zh) 2001-01-31
US20140127245A1 (en) 2014-05-08
US20030130200A1 (en) 2003-07-10
KR100629546B1 (ko) 2006-09-27

Similar Documents

Publication Publication Date Title
ATE432078T1 (de) Kleine peptide und methoden zur behandlung von asthma und entzündungen
ATE284959T1 (de) Unterbrechung der bindung der proteine mdm2 und p53 und entsprechende therapeutische anwendung
EP2327712A3 (de) Behandlung von Autoimmunkrankheiten mittels Copolymer 1 und ähnlichen Copolymeren und Peptiden
IL105554A0 (en) Peptides of human papilloma virus for use in human t cell response inducing compositions
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
BR0213786A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
ATE230417T1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE69835766D1 (de) Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE144535T1 (de) Plättchen blockierende peptide
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
DE68917837D1 (de) Peptid-Verbindungen.
DE69716460D1 (de) Wundheilung und behandlung von fibrose
NO983294L (no) Bowman-Birk inhibitor for hankj°nn dysfunksjon
DE69535460D1 (de) Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
ATE42308T1 (de) Pharmakologisch aktive peptide.
DE69526972D1 (de) Verwendung von Gabapentin in der Behandlung vonAngst - und Panikstörungen
BR9816097A (pt) Métodos para tratar uma reação alérgica em um mamìfero, inflamação cutânea em um mamìfero, artrite selecionada do grupo que consiste de osteoartrite, artrite psoriática, lupus, e espondilartrite, doença pulmonar de obstrução crÈnica em um paciente, doença de intestino inflamatória crÈnica em um paciente, para inibir a infiltração de eosinófilos em vias aéreas de um paciente, a liberação de mucosa em vias áreas de um paciente, para bloquear a ativação ige de um linfócito, para estabilizar a membrana da célula de um linfócito, e para inibir a migração de células-t
AU4712993A (en) New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
ATE510008T1 (de) Entzündungshemmende peptide
ATE215361T1 (de) Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv
EA200200169A1 (ru) МАЛЫЕ ПЕПТИДЫ И СПОСОБЫ ПОНИЖАЮЩЕЙ РЕГУЛЯЦИИ IgE
WO1994024150A3 (en) Pepstatin derivatives for treatment, prevention and detection of infections
SE9603466D0 (sv) New compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037651

Country of ref document: EP